Sep 19 |
Biotech Stock Roundup: GILD, NUVL Stocks Surge on Study Data, MRNA Down on Updates
|
Sep 17 |
FDA lifts partial clinical hold on Zentalis Pharma’s cancer WEE1 inhibitor
|
Sep 17 |
Zentalis Stock Up as FDA Lifts Partial Hold on Cancer Drug Studies
|
Sep 16 |
Zentalis stock rises after FDA lifts partial clinical hold on azenosertib studies
|
Sep 16 |
FDA Removes Partial Hold On Zentalis Pharmaceuticals' Azenosertib Studies In Patients With Gynecological Cancers
|
Sep 16 |
Zentalis Pharmaceuticals Announces FDA Has Lifted Partial Clinical Hold on Azenosertib Studies
|
Sep 9 |
Zentalis Pharmaceuticals to Present Preclinical Azenosertib Data at ESMO 2024
|
Sep 3 |
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
|
Aug 26 |
Zentalis (ZNTL) Plunges More Than 70% in 3 Months: Here's Why
|
Aug 9 |
Zentalis Pharmaceuticals GAAP EPS of -$1.24
|